Eli Lilly plans to slash some insulin prices, expand cost cap
The drugmaker says it will immediately cap monthly out-of-pocket costs at $35 for people who are not covered by Medicare's prescription drug program.
The drugmaker says it will immediately cap monthly out-of-pocket costs at $35 for people who are not covered by Medicare's prescription drug program.